Study of Combined GARP:TGF-β1/PD-1 Blockade as a Shock-and-kill Strategy in HIV-1 Cure
Clinical trial NCT07692932 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07692932
- Sponsor
- Cliniques universitaires Saint-Luc- Université Catholique de Louvain
- Status
- NOT_YET_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-31
- Primary completion
- 2030-12-31
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.